Accord Hlthcare Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ACCORD HLTHCARE INC, and what generic and branded alternatives to ACCORD HLTHCARE INC drugs are available?
ACCORD HLTHCARE INC has three approved drugs.
There are two tentative approvals on ACCORD HLTHCARE INC drugs.
Summary for Accord Hlthcare Inc
| US Patents: | 0 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 3 |
Drugs and US Patents for Accord Hlthcare Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accord Hlthcare Inc | AMLODIPINE AND OLMESARTAN MEDOXOMIL | amlodipine besylate; olmesartan medoxomil | TABLET;ORAL | 209600-004 | Aug 30, 2018 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Accord Hlthcare Inc | TIGECYCLINE | tigecycline | POWDER;INTRAVENOUS | 208744-001 | Jan 18, 2018 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Accord Hlthcare Inc | AMLODIPINE AND OLMESARTAN MEDOXOMIL | amlodipine besylate; olmesartan medoxomil | TABLET;ORAL | 209600-001 | Aug 30, 2018 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Accord Hlthcare Inc | AMLODIPINE AND OLMESARTAN MEDOXOMIL | amlodipine besylate; olmesartan medoxomil | TABLET;ORAL | 209600-003 | Aug 30, 2018 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
